Holostem s.r.l.

6 clinical trials · Sponsor

Record	Firm	Date
Open-label, Pivotal Clinical Trial to Confirm Efficacy and Safety of Autologous Grafts Containing Stem Cells Genetically Modified for Epidermis Restoration in Patients With Junctional Epidermolysis Bullosa (NCT05111600)	Holostem s.r.l.	2022-07-15
Clinical Trial to Assess the Safety and Efficacy of Investigational Product in Patients Due to Hypospadias Treatment Failure (NCT05093166)	Holostem s.r.l.	2021-11-26
Clinical Trial to Assess Safety and Efficacy of Autologous Cultured Epidermal Grafts Containing Epidermal Stem Cells Genetically Modified in Patients With JEB (HOLOGENE17) (NCT03490331)	Holostem s.r.l.	2018-03-19
Follow-up Study After ACLSCT for Restoration of Corneal Epithelium in Patients With LSCD Due to Ocular Burns (NCT03288844)	Holostem s.r.l.	2017-12-13
Clinical Trial to Assess Safety and Efficacy of Autologous Cultured Epidermal Grafts Containing Epidermal Stem Cells Genetically Modified in Patients With RDEB. (NCT02984085)	Holostem s.r.l.	2017-01-30
Efficacy and Safety of Autologous Cultivated Limbal Stem Cells Transplantation (ACLSCT) for Restoration of Corneal Epithelium in Patients With Limbal Stem Cell Deficiency (NCT02577861)	Holostem s.r.l.	2015-10-01

Every clearance here is in the API, with alerts when new ones post.